دورية أكاديمية

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience

التفاصيل البيبلوغرافية
العنوان: Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience
المؤلفون: De Novellis, DaniloAff1, Aff2, Fontana, Raffaele, Palmieri, Salvatore, Della Pepa, Roberta, Di Perna, Maria, Cetani, Giusy, Esposito, Daniela, Amendola, Angela, Delle Cave, Giuseppe, Serio, Bianca, Morini, Denise, Rizzo, Michela, Mettivier, Laura, Trastulli, Fabio, Rocco, Stefano, Pagano, Anastasia, Barbato, Serafina, Leone, Aldo, La Magna, Martina, Bianco, Rosario, Rascato, Gabriella, Carobene, Angela, Cuffa, Bianca, Iannalfo, Marialuigia, Giudice, ValentinaAff1, Aff2, IDs11523023010014_cor25, Svanera, Gino, Annunziata, Mario, Pizzuti, Michele, Frigeri, Ferdinando, Califano, Catello, Ferrara, Felicetto, Pane, Fabrizio, Selleri, CarmineAff1, Aff2, IDs11523023010014_cor33
المصدر: Targeted Oncology. 18(6):885-892
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17762596
1776260X
DOI:10.1007/s11523-023-01001-4